Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B

NCT07282249 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

630

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic hepatitisB

Interventions

DRUG: TVAV-008
DRUG: PegIFNα2b
DRUG: Placeb

Sponsor

Grand Theravac Life Sciences (Nanjing) Co., Ltd.